Heart failure in Poland: Left ventricular assist device destination therapy and other challenges of interventional cardiology and cardiac surgery

被引：3

作者：

Kusmierczyk, Mariusz ^{[1
]}

Rozanski, Jacek ^{[1
]}

Zembala, Michal ^{[2
]}

Dudek, Dariusz ^{[3
,4
]}

Braksator, Wojciech ^{[5
]}

Grodzicki, Tomasz ^{[6
]}

Hoffman, Piotr ^{[7
]}

Sadowski, Jerzy ^{[3
,8
]}

Gruchala, Marcin ^{[9
]}

Legutko, Jacek ^{[3
,10
]}

Siondalski, Piotr ^{[11
]}

Wierzbicki, Karol ^{[3
,8
]}

Kapelak, Boguslaw ^{[3
,8
]}

Opolski, Grzegorz ^{[12
]}

Juraszek, Andrzej ^{[1
]}

Bondaryk, Katarzyna ^{[13
]}

Walczak, Jacek ^{[14
]}

Pieniazek, Izabela ^{[14
]}

Grys, Maciej ^{[14
]}

Przygodzki, Piotr ^{[15
]}

机构：

[1] Natl Inst Cardiol, Dept Cardiac Surg & Transplantol, Warsaw, Poland

[2] Heart & Lung Transplantat & Mech Circulatory Supp, Dept Cardiac Surg, Zabrze, Poland

[3] Jagiellonian Univ, Inst Cardiol, Med Coll, Krakow, Poland

[4] Maria Cecilia Hosp, GVM Care & Res, Ravenna, Italy

[5] Med Univ Warsaw, Dept Sports Cardiol & Noninvas Cardiac Imaging, Med Fac 2, Warsaw, Poland

[6] Jagiellonian Univ, Med Coll, Dept Internal Med & Gerontol, Krakow, Poland

[7] Natl Inst Cardiol, Dept Congenital Heart Dis, Warsaw, Poland

[8] John Paul 2 Hosp, Dept Cardiovasc Surg & Transplantol, Krakow, Poland

[9] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland

[10] John Paul 2 Hosp, Dept Intervent Cardiol, Krakow, Poland

[11] Med Univ Gdansk, Cardiac & Vasc Surg Dept, Gdansk, Poland

[12] Med Univ Warsaw, Chair & Dept Cardiol 1, Warsaw, Poland

[13] Law Off Bondaryk, Warsaw, Poland

[14] Arcana Inst, Krakow, Poland

[15] Abbott Hlth Econ & Reimbursement, Warsaw, Poland

来源：

CARDIOLOGY JOURNAL | 2020年 / 27卷 / 06期

关键词：

heart failure; left ventricular assist device; destination therapy; extracorporeal membrane oxygenation; dilated cardiomyopathy; GUIDELINES; CARE;

D O I：

10.5603/CJ.a2020.0148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with severe heart failure (HF), who are not eligible for cardiac transplantation and receive optimal medical management, based mainly on the use of pharmacological treatment and devices such as resynchronization therapy (implantable cardioverter-defibrillator), achieve poor clinical outcomes and constitute a group with extremely poor prognosis. Currently, the technology used in the latest generation left ventricular assist devices (LVADs), such as the HeartMate 3, makes it possible to achieve patient survival at the level obtained by patients after heart transplantation, and they can be used not only in patients eligible for heart transplantation as a bridge to transplant, but also in those with significantly worse prognosis, who are ineligible for heart transplantation as destination therapy. The objective of this publication is to present recommendations from experts in cardiology and cardiac surgery, supported by clinical trial results, on the use of LVADs as a destination therapy in HF patients who are not eligible for cardiac transplantation. The paper also presents the issue of cardiac transplantation and extracorporeal membrane oxygenation therapy in Poland, as well as current challenges faced by interventional cardiology and cardiac surgery in Poland.

引用

页码：693 / 704

页数：12

共 25 条

[1]

[Anonymous], 2018, PRIORYTETY ZDROWOTNE

[2]

Arendarczyk A., 2017, FOLIA CARDIOL, V12, P113, DOI [10.5603/FC.2017.0016, DOI 10.5603/FC.2017.0016]

[3] Extracorporeal Membrane Oxygenation is an Effective Bridge to Left Ventricular Assist Device Implantation [J].

Ayers, B. C. ;

Sagebin, F. ;

Wood, K. ;

Barrus, B. ;

Prasad, S. ;

Gosev, I. .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04) :S436-S436

[4]

Bielecka A., 2007, FOLIA CARDIOLOGICA E, V2, P54

[5]

Drabik A., 2017, INZYNIER FIZYK MEDYC, V6, P57

[6]

Dudek D, 2019, CARDIOL J, V26, P114, DOI [10.5603/CJ.a2019.0007, 10.5603/CJ.2019.0007]

[7] Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial [J].

Goldstein, Daniel J. ;

Naka, Yoshifumi ;

Horstmanshof, Douglas ;

Ravichandran, Ashwin K. ;

Schroder, Jacob ;

Ransom, John ;

Itoh, Akinobu ;

Uriel, Nir ;

Cleveland, Joseph C., Jr. ;

Raval, Nirav Y. ;

Cogswell, Rebecca ;

Suarez, Erik E. ;

Lowes, Brian D. ;

Kim, Gene ;

Bonde, Pramod ;

Sheikh, Farooq H. ;

Sood, Poornima ;

Farrar, David J. ;

Mehra, Mandeep R. .

JAMA CARDIOLOGY, 2020, 5 (04) :411-419

[8] Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations [J].

Han, Jooli ;

Trumble, Dennis R. .

BIOENGINEERING-BASEL, 2019, 6 (01)

[9] Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support [J].

Lamarche, Yoan ;

Cheung, Anson ;

Ignaszewski, Andrew ;

Higgins, Jennifer ;

Kaan, Annemarie ;

Griesdale, Donald E. G. ;

Moss, Robert .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (01) :60-65

[10] A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report [J].

Mehra, M. R. ;

Uriel, N. ;

Naka, Y. ;

Cleveland, J. C., Jr. ;

Yuzefpolskaya, M. ;

Salerno, C. T. ;

Walsh, M. N. ;

Milano, C. A. ;

Patel, C. B. ;

Hutchins, S. W. ;

Ransom, J. ;

Ewald, G. A. ;

Itoh, A. ;

Raval, N. Y. ;

Silvestry, S. C. ;

Cogswell, R. ;

John, R. ;

Bhimaraj, A. ;

Bruckner, B. A. ;

Lowes, B. D. ;

Um, J. Y. ;

Jeevanandam, V. ;

Sayer, G. ;

Mangi, A. A. ;

Molina, E. J. ;

Sheikh, F. ;

Aaronson, K. ;

Pagani, F. D. ;

Cotts, W. G. ;

Tatooles, A. J. ;

Babu, A. ;

Chomsky, D. ;

Katz, J. N. ;

Tessmann, P. B. ;

Dean, D. ;

Krishnamoorthy, A. ;

Chuang, J. ;

Topuria, I. ;

Sood, P. ;

Goldstein, D. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (17) :1618-1627

← 1 2 3 →